Dialogical Medication Therapy Safety
Donnerstag, 6. März 2025
Dialogical medication therapy safety is crucial. A case demonstrates how a lack of communication between doctors and pharmacists can lead to dangerous misunderstandings. Relying on digital solutions is not enough—direct conversations are essential.
Foto von Usman Yousaf auf Unsplash
Is there such a thing? Dialogical medication therapy safety?
On a Friday afternoon in March 2025, I stumbled upon a LinkedIn post by a pharmacist. It captures my attention because several experts from my network have already commented on it. The pharmacist describes a case where she advised a patient against taking two medications simultaneously. However, the patient received feedback from two doctors that the combination was fine.
I wonder: Did the patient really speak with both doctors? The simple confirmation seems superficial. Presumably, the patient did not fulfill her responsibility and avoided direct confrontation.
How should professionals proceed in such situations? The lack of dialogue between the pharmacy, general practitioner, and specialist is concerning. Often, rigid processes and responsibilities, as well as personal sensitivities, prevent constructive collaboration.
In my opinion, we should not blindly rely on care pathways or digital tools like the electronic patient record (ePA). This individual case shows that. Until the ePA offers a reliable medication therapy safety check, direct communication between all parties involved remains essential – especially when it comes to life and death.
More Recent Post
Earlier Contribution
